Antitumor effect of dipyridamole mediated by inhibiting the interaction between platelets and tumor cells
Jie Xue, Jianzhao Deng, Hongwei Qin, Ying Li, Zhongcui Jing, Zhen Zhao, Haiyan Wang · 2026
Read Antitumor effect of dipyridamole mediated by inhibiting the interaction between platelets and tumor cells by Jie Xue, Jianzhao Deng, Hongwei Qin, Ying Li, Zhongcui Jing, Zhen Zhao, Haiyan Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13522310.txt.
Description
Jie Xue and colleagues review in 2026 the anticancer potential of dipyridamole, a long-used anti-clotting and vessel-widening drug, focusing on how platelets shield travelling cancer cells and help them seed new tumours.
Once cancer cells enter blood, platelet clumps protect them from immune attack and trigger shape changes that favour spread. Dipyridamole blocks platelet clumping and interrupts that shape-change programme through a growth signalling pathway, according to gathered studies. Mechanistic evidence remains incomplete and scattered, which the review organises by pathway. Repurposing a cheap, familiar drug appeals strongly, yet patient-level proof of anticancer benefit is still lacking.
Catalog record
| CREATOR | Jie Xue, Jianzhao Deng, Hongwei Qin, Ying Li, Zhongcui Jing, Zhen Zhao, Haiyan Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29592 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |